Journal
AMERICAN JOURNAL ON ADDICTIONS
Volume 17, Issue 5, Pages 396-401Publisher
WILEY-BLACKWELL
DOI: 10.1080/10550490802268835
Keywords
-
Categories
Funding
- NIDA NIH HHS [R01 DA015842-05, R01 DA015842] Funding Source: Medline
- NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015842] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Attitudes and beliefs about drug abuse treatment have long been known to shape response to that treatment. Two major pharmacological alternatives are available for opioid dependence: methadone, which has been available for the past 40 years, and buprenorphine, a recently introduced medication. This mixed-methods study examined the attitudes of opioid-dependent individuals toward methadone and buprenorphine. A total of 195 participants (n = 140 who were enrolling in one of six Baltimore area methadone programs and n = 55 who were out-of-treatment) were administered the Attitudes toward Methadone and toward Buprenorphine Scales, and a subset (n = 46) received an ethnographic interview. The in-treatment group had significantly more positive attitudes toward methadone than did the out-of-treatment group (p < .001), while they did not differ in their attitudes toward buprenorphine. Both groups had significantly more positive attitudes toward buprenorphine than methadone. Addressing these attitudes may increase treatment entry and retention.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available